Quick answer: The FDA declined to approve MDMA-assisted therapy for PTSD, citing gaps in safety data, questions about how long the benefits last, and concerns about who was enrolled in the trials. The rejection letter is now public. It does not mean MDMA therapy is...
RFK Jr. psychedelic therapy support has brought significant new attention to substances like psilocybin, MDMA, and ibogaine as legitimate tools for mental health care. For seekers who have been quietly researching this space, the political shift is real but so is the...
Psychedelic therapy for veterans is one of the most actively researched areas in mental health today. Clinical trials involving MDMA and psilocybin have shown meaningful reductions in PTSD symptoms for people who found little relief through conventional care. This...
Texas has committed $50 million to fund clinical trials for ibogaine treatment Texas programs focused on veterans and first responders. The research is early and the risks are real, but the implications for PTSD, addiction, and traumatic brain injury are significant...
